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Abstract
Introduction: The present study compared the effect of bupivacaine and bupivacaine + sufentanil on hemodynamic 
parameters and characteristics of spinal anesthesia in elderly patients undergoing transurethral resection of the 
prostate (TURP) under spinal anesthesia. 
Technical Considerations: The study included 40 American Society of Anesthesiologists (ASA) I-III patients scheduled 
to undergo TURP. Patients were blindly and randomly divided into two groups. Group B (n = 20) received 10 mg of 
intrathecal bupivacaine and group BS (n = 20) received 7.5 mg of bupivacaine + 5 µg of sufentanil. Sensory and motor 
block characteristics, hemodynamic changes, side effects, and time to first analgesic requirement were recorded. No 
differences in mean arterial pressure or heart rate, time for sensory blockade to reach the T10 level, and maximum sensory 
level were observed between the two groups. The time to first analgesic request was longer in group BS (P < 0.05). 
Motor block was significantly higher in group B (P < 0.05). In terms of side effects, no statistically significant differences 
occurred between the groups. 
Conclusions: Similar hemodynamic stability and sufficient level of sensory blockade were provided by bupivacaine and 
bupivacaine + sufentanil used for spinal anesthesia in patients undergoing TUR. Due to the fact that less motor block 
was observed and the time to first analgesic request was longer, the combination of bupivacaine + sufentanil might be 
appropriate for patients undergoing TUR.
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Introduction
Transurethral resection of the prostate (TURP) interventions 
is primarily transient, and due to the fact that a large number 
of elderly patients undergo these interventions; reducing 
complications, early hospital discharge, and reducing 
the cost of treatment are desirable.[1,2] Sufficient spinal 
anesthesia with fewer side effects, less intense motor block 
of shorter duration, and rapid recovery can be obtained by 
combining opioids and lower doses of local anesthetics.[3‑6] 
Sufentanil has a µ‑receptor ligand and is able to produce 
spinal‑type analgesia preserving motor function of lower 
extremities and is a lipophilic opioid, improve intraoperative, 
and postoperative analgesia with no adverse effects.[3] As 
such, safe anesthesia can be accomplished in elderly and 
high‑risk patients. Many studies[7‑10] have included obstetric 
patients to determine the effects, safety, and most effective 
dose of combining intrathecalsufentaniland lower doses 
of local anesthetics. However, the number of studies that 
examined the effects of intrathecalsufentanil in elderly 
patients undergoing urological surgery is limited.
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We hypothesized that intrathecal bupivacaine + sufentanil 
would provide a more adequate spinal block without 
hemodynamic side effects for TURP operation than 
subarachnoid bupivacaine in elderly patients undergoing 
TURP.
Materials and Methods
This study was approved by the hospital ethics committee 
of Ankara Oncology Hospital. We obtained written 
informed consent from 40 American Society of 
Anesthesiologists (ASA) I‑III patients undergoing elective 
TURP for benign prostatic hypertrophy. Patients with 
a history of back surgery, mental retardation, infection 
at injection sites, coagulopathy, a history of opioid and 
chronic analgesic use, hypersensitivity to local anesthetics 
or opioids, diabetes, peripheral neuropathy, coronary artery 
disease, advanced cardiac valve disease, or an ejection 
fraction <50% were excluded from the study.
This study was conducted in a randomized, double blind, 
single center fashion, and performed between May 2006 and 
October 2006. One of the investigators prepared the drug 
solution before anesthesia. The anesthetic administrator 
and the patients were blinded to the type of drug solution 
and the patient groups. Patients were allocated into 
two groups using a random number sequence. Group B 
(bupivacaine group) received bupivacaine 0.5% (2 ml) 
(10 mg) (Marcaine Spinal Heavy; Astra, Sodertalje, Sweden) 
+ dextrose %10 (0.8 ml) (80 mg)+ distilled water (0.2 ml) 
in total 3 ml drug mixture, and group BS (bupivacaine plus 
sufentanil) received bupivacaine 0.5% (7.5 mg) +5 μg of 
sufentanil (Sufenta, Janssen‑Cilag) + dextrose% 30 (0.4 ml) 
(120 mg) + distilled water (0.1 ml) in total 3 ml drug mixture.
First, 0.05‑0.07 mg/kg of midazolam and 0.5 mg of 
atropine with intramuscular premedication were 
administered to the patients 30 min before TURP 
surgery; electrocardiograph (ECG), non‑invasive 
arterial pressure, and peripheral oxygen saturation were 
monitored (PetasKMA® 800). Before spinal anesthesia, the 
patients received 7‑8 mL/kg i.v. lactated ringer over 20 min. 
Spinal puncture was performed at L 4‑5 with a 25 G Quincke 
needle with the patient in sitting position. After the free 
flow of clear cerebrospinal fluid (CSF) was observed, the 
drug mixture was given within 2 min and the patients were 
placed in a sitting position for 5 min and then in supine 
position until the sensory block peaked. The level of sensory 
block, defined as the dermatomal segment with loss of pain 
sensation to cold alcohol swap and pin‑prick test with a 22G 
hypodermic needle and on each side of the mid‑thoracic 
line, was measured every 2 min, until it reached the peak 
level with four consecutive tests and then every 10 min 
during the surgery. We recorded time for sensory blockade 
to reach the T10 level, the duration of motor blockade, 
the first analgesic request after operation. The duration of 
motor blockade was defined as the time that had elapsed 
between injection and total recovery of motility by the feet. 
Motor blockade in the lower limbs was recorded bilaterally 
using a modified Bromage scale, as follows: 0 = no block; 
1 = minimal block (difficulty moving feet); 2 = medium 
block (difficulty raising legs); 3 = high block (complete 
paralysis). Motor and sensory blockades were evaluated.
The quality of anesthesia was assessed as excellent (no 
discomfort or pain), good (mild pain or discomfort, no 
need for additional analgesics), fair (pain that required 
analgesics), or poor (severe pain that required analgesics) 
during the operation. During the preoperative period, all 
patients were instructed to assess the severity of their pain 
using a 10‑point verbal analog pain scale (VAPS; scores 
range from 0, which indicates no pain, to 10, which indicates 
the worst pain imaginable). If the patient experienced mild 
discomfort (VAPS between 3 and 6), additional anesthesia 
was provided using i.v. propofol bolus.
Adverse effects such as hypotension, bradycardia, nausea 
or vomiting, pruritus, shivering, and respiratory depression 
were recorded during the operation and recovery. Data 
mean arterial pressure (MAP), and heart rate (HR), 
SpO2 were recorded 5, 10, 15, 20, 25,30,40, 50, 60,75,90, 
105,120 minutes.
Hypotension was defined by a decrease in SAP to, 90 
mm Hg or, 75% from the baseline value, and bradycardia 
was defined as HR of less than 45 beats min. whereas 
hypotension was treated with 5‑10mg ephedrine i.v. bolus 
doses, bradycardia was treated with 0.5 mg of i.v. atropine. 
Hypoxemia was defined as oxygen saturation under 95%, 
which was treated with ventilatory support via facemask 
with higher oxygen flow.
Statistical analysis was carried out using Statistical Package 
for Social Sciences (SPSS) v. 11.0 for Windows (Chicago, 
IL, USA). The unpaired t test, Mann Whitney‑U test, 
and chi square test were used for statistical analysis, as 
applicable. Friedman’s test was used to compare arterial 
pressure, and heart rate values. Differences between arterial 
pressure and heart rate parameters were evaluated using the 
Wilcoxon marked serial test with Bonferroni correction.
Results
Spinal anesthesia was successfully accomplished in all 
patients. No technical difficulties were encountered 
during surgery, which in all cases was uneventful. Patient 
characteristics were similar between the groups [Table 1]. 
The overall quality of spinal anesthesia was also similar in 
both groups (P > 0.05). No significant differences were 
found in MAP and HR between the groups. Intra group 
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analysis ofhemodynamic parameters in both groups showed 
a significant decrease in mean arterial pressure and heart 
rate at 5 minutes later than spinal block, as compare to 
basal values (P < 0.05) [Figures 1 and 2]. In group B, the 
decrease in MAP was more than that in group BS but this 
difference was not statistically significant. Bradycardia, 
which developed in four patients in group B (20%) and in 
one patient in group BS (5%), was treated with 0.5 mg of 
i.v. atropine. The difference between the groups, in terms 
of treatment requirements, was not statistically significant.
There were no significant differences in time for sensory 
blockade to reach the T10 level and maximum sensorial 
level between the groups. In group B, motor block was 
observed significantly more frequently and longer than in 
group BS (P < 0.05). The time to the first analgesic request 
was longer in group BS (P < 0.05) [Table 2].
In terms of side effects, no statistically significant differences 
occurred between the groups. Itching was observed in 
three patients (15%) in group BS. None of the patients 
experienced nausea, vomiting, shivering or respiratory 
depression.
Discussion
In this study, we found that the addition of sufentanil 5 µgto 
a small‑dose bupivacaine for spinal anesthesia effectively 
decreasedthe motor block level, time to regression of motor 
block andincreasing postoperative analgesic request time 
without increasing the hemodynamic or another side effects 
in elderly patients.
In the present study, the maximum level of sensory 
block was T8 in both groups. Active anesthesia in sacral 
regions, and sufficient analgesia at the lumbar and 
thoracic levels were obtained. Motor block was longer in 
group B (159.1 ± 42.1 min) than in group BS (134.0 ± 31) 
and group B patients experienced intense motor blockade, 
whereas group BS patients showed a negligible motor 
impairment. Although, 10 mg of bupivacaine provided a 
satisfactory level of analgesia, it had the disadvantage of 
inducing a motor blockade whose intensity and duration 
greatly exceeded the requirements for a short‑lasting 
procedure such as TURP. We think that less motor block 
had a positive effect on postoperative recovery in patients 
with early mobilization. This result, significantly less motor 
blockade in the BS group, may be one of features of the 
mixture of bupivacaine and sufentanil.
Development of hypotension during spinal anesthesia in 
geriatric patients is common.[11,12]
The opioids, which are added to local anesthetics, may 
provide lowering the dosages of both medications; in 
addition, this combination may decrease the hemodynamic 
side effects.[7,13] The addition of sufentanil to low dose 
bupivacaine (7.5 mg) has been reported to cause fewer 
hemodynamic effects.[11] Previous studies have also shown 
that the use of intrathecalsufentanil did not cause changes in 
sympathetic response, heart rate, or blood pressure.[14,15] We 
did not observe statistically significant intergroup differences 
in circulatory variables.
There was no benefit in increasing intrathecal dose 
beyond sufentanil 5 µg in regard to duration of analgesia 
in a previous study.[8] Two independent studies have 
revealed that the median effective dose (ED50) of 
intrathecalsufentanilwas 2.6 µg.[7,9] Therefore, intrathecal 
sufentanil 5 µgcould be considered as an equipotent dose 
and we used sufentanil 5 µg. The duration of postoperative 
analgesia for sufentanil was previously reported to be 4 h and 
5 h, after intrathecal administration as an adjunct to surgical 
spinal anesthesia and analgesia.[16] Dahlgren[10] concluded 
that addition of small doses of fentanyl and sufentanil 
to bupivacaine intrathecally increased the duration of 
analgesia in the postoperative period. Although, it has 
been reported that the effects of postoperative analgesia are 
brief after intrathecal administration of sufentanil because 
of its rapid clearance from the cerebrospinalfluid (CSF),[17] 
in our study, the time to the first analgesic request 
was longer in the group BS (288.6 ± 32.7 min.) than 
group B (250.1 ± 33.8 min.) in elderly patients undergoing 
TURP. These results are consistent with the results of studies 
demonstrating that intrathecal opioids enhance analgesia 
when added to subtherapeutic doses of local anesthetics.[18] 







Age (years)* 61±11 64±9 0.203
Gender (M/F) 17/3 18/2 1.000
Weight (kg)* 72±7 73±7 0.478
ASA (I/II/III) 6/11/3 5/13/2
Duration of 
surgery (min)**
30 (15-90) 40 (20-70) 0.192
*Values are mean ± SD (range), **Values are median (min‑max). 
SD=Standard deviation; ASA=American Society of Anesthesiologists






Time to reach T10 level (min)* 15 (5-30) 12.5 (5-30)
Maximum sensory level * T8 (T11-T6) T8 (T10-T4)
Motor block ending time (min)** 159±42 134±31
Time to the first analgesic 
requirement**
250.1±33.8 288.6±32.7
Motor block (Bromage: 0/1/2/3) 0/5/5/10 13/5/0/2
* Values are median (min‑max),**Values are mean ± SD (range). 
SD=Standard deviation
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Further, research investigating differences in the inherent 
physiochemical properties of intrathecal opioids in elderly 
patients is warranted.
Intrathecal administration of opioids can cause such 
side effects as itching, nausea, vomiting, and respiratory 
depression. The frequency and severity of side effects depend 
Figure 1: Differences in mean arterial blood pressure between groups (P	>	0.05)
Figure 2: Differences in heart rate between groups (P	>	0.05)
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on the dose and they are observed in a fairly low incidence. 
Opioids cause itching by stimulating μreceptors in the 
posterior horn. Agonist‑stimulating κ(kappa) receptors, 
on the other hand, prevent itching.[19] Intrathecal use of 
the same dose sufentanil and itching incidence is reported 
differently in various studies.[20‑22] In the present study, the 
incidence of itching may have been low because opioids 
were administered in low doses.
Conclusion
7.5 mg of bupivacaine and 5 µg of sufentanil; provides 
adequate anesthesia without hemodynamic instability, 
fewer side effect, and less motor block for TURP in 
elderly patients. Sufentanil facilitates the spread of the 
block and offers greater postoperative analgesic efficacy. 
Due to the fact that less motor block was observed and 
the first analgesic request was longer, the combination of 
bupivacaine + sufentanil might be appropriate for elderly 
patients undergoing TURP.
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